Oct. 1 at 11:11 PM
$OCUL sounds like they know its a coin flip and dont want to take the risk of finding out and not having any money.
the whole scaring big pharma is an old story. big pharma knows it and will call the bluff unless they are non-US. see Apellis.
Pravin is now Apellis…he is trailblazing on new trial design and endpoints where
$EYPT is Iveric, riding Ocular’s coat tails with cheaper deal.
$OCUL’s market is so high, no big pharma will pay them
$7.5B (3x their market cap)
